The label also states an explicit limitation of use: concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products, or with any other GLP-1 receptor agonist, is not recommended
That said, individuals who may benefit include: Adults with a Body Mass Index (BMI) of 30 or higher People in this category are generally considered to have obesity by clinical standards
If you are starting Ozempic as part of your weight management with us, its important to store your medication correctly before taking your first dose
THE Medicines and Healthcare products Regulatory Agency (MHRA), in partnership with Genomics England, has announced a new phase of research under the Yellow Card Biobank initiative
Available at: 1047
Dose Escalation: Why Starting Low Reduces Side Effects Because the body needs time to adapt to semaglutide's effects , Wegovy treatment follows a calculated dose escalation strategy that begins with a minimal weekly dose of 0.25 mg